IOVANCE BIOTHERAPEUTICS INC (IOVA) — insider trading
Health Care · NASDAQ
IOVANCE BIOTHERAPEUTICS INC (IOVA) has 59 reported SEC Form 4 insider transactions in our data (latest 2026-09-30).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-30 | Berkowitz Noah | Officer (Chief Medical Officer) | Grant / award / vesting (derivative) | 135,000 | — | $0 | Form 4 |
| 2026-09-30 | Berkowitz Noah | Officer (Chief Medical Officer) | Grant / award / vesting (derivative) | 180,000 | — | $0 | Form 4 |
| 2026-09-30 | Berkowitz Noah | Officer (Chief Medical Officer) | Grant / award / vesting (derivative) | 135,000 | — | $0 | Form 4 |
| 2026-09-08 | Vogt Frederick G | Director, Officer (Interim CEO & General Counsel) | Option exercise / conversion (derivative) | 15,626 | — | $0 | Form 4 |
| 2026-09-08 | Vogt Frederick G | Director, Officer (Interim CEO & General Counsel) | Shares withheld for taxes / exercise cost | 6,638 | $8.70 | $57.8K | Form 4 |
| 2026-09-08 | Vogt Frederick G | Director, Officer (Interim CEO & General Counsel) | Option exercise / conversion | 15,626 | — | $0 | Form 4 |
| 2026-09-08 | Puri Raj K. | Officer (Chief Regulatory Officer) | Option exercise / conversion (derivative) | 9,766 | — | $0 | Form 4 |
| 2026-09-08 | Puri Raj K. | Officer (Chief Regulatory Officer) | Shares withheld for taxes / exercise cost | 4,478 | $8.70 | $39.0K | Form 4 |
| 2026-09-08 | Puri Raj K. | Officer (Chief Regulatory Officer) | Option exercise / conversion | 9,766 | — | $0 | Form 4 |
| 2026-09-08 | BILINSKY IGOR | Officer (Chief Operating Officer) | Option exercise / conversion (derivative) | 7,813 | — | $0 | Form 4 |
| 2026-09-08 | BILINSKY IGOR | Officer (Chief Operating Officer) | Shares withheld for taxes / exercise cost | 3,976 | $8.70 | $34.6K | Form 4 |
| 2026-09-08 | BILINSKY IGOR | Officer (Chief Operating Officer) | Option exercise / conversion | 7,813 | — | $0 | Form 4 |
| 2026-09-01 | Vogt Frederick G | Director, Officer (Interim CEO & General Counsel) | Option exercise / conversion (derivative) | 41,669 | — | $0 | Form 4 |
| 2026-09-01 | Vogt Frederick G | Director, Officer (Interim CEO & General Counsel) | Shares withheld for taxes / exercise cost | 17,702 | $8.28 | $146.6K | Form 4 |
| 2026-09-01 | Vogt Frederick G | Director, Officer (Interim CEO & General Counsel) | Option exercise / conversion | 41,669 | — | $0 | Form 4 |
| 2026-09-01 | Puri Raj K. | Officer (Chief Regulatory Officer) | Option exercise / conversion (derivative) | 5,470 | — | $0 | Form 4 |
| 2026-09-01 | Puri Raj K. | Officer (Chief Regulatory Officer) | Shares withheld for taxes / exercise cost | 2,508 | $8.28 | $20.8K | Form 4 |
| 2026-09-01 | Puri Raj K. | Officer (Chief Regulatory Officer) | Option exercise / conversion | 5,470 | — | $0 | Form 4 |
| 2026-09-01 | BILINSKY IGOR | Officer (Chief Operating Officer) | Option exercise / conversion (derivative) | 8,789 | — | $0 | Form 4 |
| 2026-09-01 | BILINSKY IGOR | Officer (Chief Operating Officer) | Shares withheld for taxes / exercise cost | 4,472 | $8.28 | $37.0K | Form 4 |
| 2026-09-01 | BILINSKY IGOR | Officer (Chief Operating Officer) | Option exercise / conversion | 8,789 | — | $0 | Form 4 |
| 2026-08-10 | Kirby Daniel Gordon | Officer (Chief Commercial Officer) | Option exercise / conversion (derivative) | 10,001 | — | $0 | Form 4 |
| 2026-08-10 | Kirby Daniel Gordon | Officer (Chief Commercial Officer) | Shares withheld for taxes / exercise cost | 2,436 | $6.40 | $15.6K | Form 4 |
| 2026-08-10 | Kirby Daniel Gordon | Officer (Chief Commercial Officer) | Option exercise / conversion | 10,001 | — | $0 | Form 4 |
| 2026-08-06 | Roche Corleen M. | Officer (Chief Financial Officer) | Option exercise / conversion (derivative) | 49,995 | — | $0 | Form 4 |
| 2026-08-06 | Roche Corleen M. | Officer (Chief Financial Officer) | Shares withheld for taxes / exercise cost | 21,238 | $6.21 | $131.9K | Form 4 |
| 2026-08-06 | Roche Corleen M. | Officer (Chief Financial Officer) | Option exercise / conversion | 49,995 | — | $0 | Form 4 |
| 2026-06-16 | Puri Raj K. | Officer (Chief Regulatory Officer) | Grant / award / vesting (derivative) | 15,000 | — | $0 | Form 4 |
| 2026-06-16 | Maynard Ryan D | Director | Grant / award / vesting (derivative) | 90,316 | — | $0 | Form 4 |
| 2026-06-16 | Countouriotis Athena | Director | Grant / award / vesting (derivative) | 90,316 | — | $0 | Form 4 |
| 2026-06-16 | Dukes Iain D. | Director | Grant / award / vesting (derivative) | 180,632 | — | $0 | Form 4 |
| 2026-06-16 | WEISER MICHAEL | Director | Grant / award / vesting (derivative) | 90,316 | — | $0 | Form 4 |
| 2026-06-05 | BILINSKY IGOR | Officer (Chief Operating Officer) | Option exercise / conversion (derivative) | 7,813 | — | $0 | Form 4 |
| 2026-06-05 | BILINSKY IGOR | Officer (Chief Operating Officer) | Shares withheld for taxes / exercise cost | 3,976 | $4.23 | $16.8K | Form 4 |
| 2026-06-05 | BILINSKY IGOR | Officer (Chief Operating Officer) | Option exercise / conversion | 7,813 | — | $0 | Form 4 |
| 2026-06-05 | Puri Raj K. | Officer (Chief Regulatory Officer) | Option exercise / conversion (derivative) | 9,766 | — | $0 | Form 4 |
| 2026-06-05 | Puri Raj K. | Officer (Chief Regulatory Officer) | Shares withheld for taxes / exercise cost | 3,843 | $4.23 | $16.3K | Form 4 |
| 2026-06-05 | Puri Raj K. | Officer (Chief Regulatory Officer) | Option exercise / conversion | 9,766 | — | $0 | Form 4 |
| 2026-06-05 | GRAF FINCKENSTEIN FRIEDRICH | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 7,813 | — | $0 | Form 4 |
| 2026-06-05 | GRAF FINCKENSTEIN FRIEDRICH | Officer (Chief Medical Officer) | Shares withheld for taxes / exercise cost | 3,976 | $4.23 | $16.8K | Form 4 |
| 2026-06-05 | GRAF FINCKENSTEIN FRIEDRICH | Officer (Chief Medical Officer) | Option exercise / conversion | 7,813 | — | $0 | Form 4 |
| 2026-06-05 | Vogt Frederick G | Director, Officer (Interim CEO & General Counsel) | Option exercise / conversion (derivative) | 15,625 | — | $0 | Form 4 |
| 2026-06-05 | Vogt Frederick G | Director, Officer (Interim CEO & General Counsel) | Shares withheld for taxes / exercise cost | 6,638 | $4.23 | $28.1K | Form 4 |
| 2026-06-05 | Vogt Frederick G | Director, Officer (Interim CEO & General Counsel) | Option exercise / conversion | 15,625 | — | $0 | Form 4 |
| 2026-06-01 | BILINSKY IGOR | Officer (Chief Operating Officer) | Option exercise / conversion (derivative) | 8,790 | — | $0 | Form 4 |
| 2026-06-01 | BILINSKY IGOR | Officer (Chief Operating Officer) | Shares withheld for taxes / exercise cost | 4,473 | $3.96 | $17.7K | Form 4 |
| 2026-06-01 | BILINSKY IGOR | Officer (Chief Operating Officer) | Option exercise / conversion | 8,790 | — | $0 | Form 4 |
| 2026-06-01 | GRAF FINCKENSTEIN FRIEDRICH | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 8,790 | — | $0 | Form 4 |
| 2026-06-01 | GRAF FINCKENSTEIN FRIEDRICH | Officer (Chief Medical Officer) | Shares withheld for taxes / exercise cost | 4,473 | $3.96 | $17.7K | Form 4 |
| 2026-06-01 | GRAF FINCKENSTEIN FRIEDRICH | Officer (Chief Medical Officer) | Option exercise / conversion | 8,790 | — | $0 | Form 4 |
| 2026-06-01 | Puri Raj K. | Officer (Chief Regulatory Officer) | Option exercise / conversion (derivative) | 5,469 | — | $0 | Form 4 |
| 2026-06-01 | Puri Raj K. | Officer (Chief Regulatory Officer) | Shares withheld for taxes / exercise cost | 2,508 | $3.96 | $9.9K | Form 4 |
| 2026-06-01 | Puri Raj K. | Officer (Chief Regulatory Officer) | Option exercise / conversion | 5,469 | — | $0 | Form 4 |
| 2026-06-01 | Vogt Frederick G | Director, Officer (Interim CEO & General Counsel) | Option exercise / conversion (derivative) | 41,668 | — | $0 | Form 4 |
| 2026-06-01 | Vogt Frederick G | Director, Officer (Interim CEO & General Counsel) | Shares withheld for taxes / exercise cost | 17,701 | $3.96 | $70.1K | Form 4 |
| 2026-06-01 | Vogt Frederick G | Director, Officer (Interim CEO & General Counsel) | Option exercise / conversion | 41,668 | — | $0 | Form 4 |
| 2026-05-11 | Kirby Daniel Gordon | Officer (Chief Commercial Officer) | Option exercise / conversion (derivative) | 10,000 | — | $0 | Form 4 |
| 2026-05-11 | Kirby Daniel Gordon | Officer (Chief Commercial Officer) | Shares withheld for taxes / exercise cost | 2,435 | $3.70 | $9.0K | Form 4 |
| 2026-05-11 | Kirby Daniel Gordon | Officer (Chief Commercial Officer) | Option exercise / conversion | 10,000 | — | $0 | Form 4 |
Ask the chat about IOVA's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: IOVANCE BIOTHERAPEUTICS INC (IOVA).
Last updated 2026-09-30 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.